A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C‐reactive protein following myocardial infarction: the CADET trial

Summary. A randomized, double-blind multicenter trial—the Clopidogrel and Aspirin: Determination of the Effects on Thrombogenicity (CADET) trial—was carried out to compare the effects of clopidogrel vs. aspirin on thrombotic variables and C-reactive protein (CRP), over a 6-month period of treatment, in patients with an acute myocardial infarction within the previous 3–7 days, who were not scheduled for major surgery including coronary artery...